SlideShare a Scribd company logo
Departmental conference
 To discuss the case of a patient scheduled for elective surgery who was classified
as high risk with unmodifiable factors
SITUATION:
 T. T.
 67 years old, female
 Preoperative Diagnosis
 Metabolic syndrome , obese 3
 Proposed Operation
 Laparoscopic gastrectomy w/ reux en y bypass
 Problem:
 Patient is classified high risk endo, pulmo, cardio wise
Date of operation: Tentative
 T.T., 67 years old female, married, roman catholic, currently residing at alunahaw
st., navotas city, admitted for the first time at our institution last September 13,
2022 due to chief complaint of excessive wait gain.
 Excessive weight gain
 10 years prior to consult, patient was apparently well with medium built until
noticed increasing appetite and increase in food cravings. There was no change in
physical activities during this time.
 During the interim, there was noted weight gain. There was no food restriction, no
physical exercise.
 4 months prior to consult, patient started having difficulty in ambulation due to
increasing wait and increasing body mass, during this time, ambulation was
assisted and required support. There was also occasional dob, easy fatigability.
Consult at a clinic was done and was advised diet modification and increase in
physical exercise.
 Few days prior to consult, patient experienced pain at both knees during assisted
ambulation, consult was done at a private clinic and was prescribed unrecalled
medications.
 Persistence of symptoms prompted consult and subsequent admission to our
institution.
 Past medical history:
(+) Hypertension
(-+) Diabetes Mellitus
(+) bronchial asthma –last attack 1 month ago
 Family history:
hypertension – maternal side
Surgical history
unremarkable
 Personal and social history:
Non alchoholic
Non smoker
No illicit drug use
 General survey:
Conscious, coherent, not in cardiopulmonary distress, GCS 15
Wt. 105kgs
Bmi – 46.6kg/m2 – obese III
 Vital signs:
BP: 130/80mmhg, HR 64bpm, RR 24cpm, Temp 37.3C, 02 sat
98% on nasal cannula
 HEENT:
 Pink palpebral conjunctivae, anicteric sclerae, no naso-aural
discharge, no tonsillopharyngeal congestion, no cervical
lymphadenopathy
 mouth opening of 4cm, no limitation in Neck mobility, mallampati
classification 3, full dentition
 Short and thick neck
 Chest and Lungs:
 Symmetrical chest expansion, no retractions,
Crackles bilateral
 Cardiovascular:
Adynamic precordium, normal rate, regular rhythm, no
murmurs
 Abdomen:
Flabby, no tenderness noted
 Extremities:
No gross deformities, full and equal pulses, no cyanosis, no
edema
ANESTHETIC
ASSESSMENT AND
PLAN
 ASA Physical status 3
 Obese 3 – BMI of 46.6kg/m2
 Pneumonia-moderate risk
 Heart failure symptoms
 Aki secondary to infection
 Hypertension controlled
 Dm type 2 controlled
 IM Risk Strat: high risk
 IM Cardio: high risk
 Ecg – complete RBBB. 2d echo result of dilated left cavity
 IM Endo: high risk
 Cbg range of 68 to137, hba1c of 6.0
 IM pulmo : high risk
 Ongoing pneumonia, history if bronchial asthma, episode of desaturations
 RCRI class 3 – 2points
 dm not requiring insulin(0), hf symptoms (+1), type of surgery-intrabdominal (+1)
 Ariscat score: 66 – high risk
 67, episode of 90% o2sat (+8), recent respiratory infection (+17), upper abdominal sx (+15),
duration of more than 3 hrs, non emergency(+23)
Cbc 8/26/22
Hgb 129
hct 38.5
platelets 297
wbc 6.8
Blood chemistry 8/26/22
na 140.9
k 3.5
crea 85.9
bun 2.69
fbs 5.7
hba1c 6.7
ast 17.8
alt 11.46
Bleeding parameters 8/26/22
pt 12.2
ptt 33.5
inr 0.95
% activity 94.5
Lipid profile 8/26/22
HDL 1.43
LDL 3.15
VLDL 0.52
TRIGLYCERIDE 1.15
TOTAL CHOLESTEROL 5.10
 2d echo results
 Dilated left ventricular cavity, with adequate wall motion and contractility
 Mild mitral and pulmonary regurgitation
 Aortic sclerosis
 Ejection fraction of 69%
Chest xray
Pneumonia, bilateral
9/13/22
-patient was admitted by the surgery
department
Admitting labs requested
Medications started – omeprazole 40mg OD,
cefuroxime 750mg q8, paracetamol 300mg tiv
prn
Surgical plan of laparoscopic gastrectomy reu
en y bybass
Monitor vs q4
Monitor i/o q shift
For im, pulmo, cardio, endo clearance
9/14/22
Requested ABG
Started ceftriaxone 2g tiv OD
Started azithromycin 500mg tiv OD
Assessment
Cap –MR
Metabolic syndrome
Obese type III
Dm type 2 – controlled
Hypertension st. 2, controlled
Risk stratification – high risk
9/14/22c
Requested ABG
Started ceftriaxone 2g tiv OD
Started azithromycin 500mg tiv OD
For cbg TID premeals
Tx.
Insulin HR 10 u SC for cbg > 100mg/dl
D5050 if cbg <80mg/dl
Risk stratification – high risk
9/15/22
Bp 140/80, hr 74, rr 20, o2 sat 96%
2d echo – dilated left ventricular cavity qith
adequate contractility and wall motion, EF 69%
Continue amlodipine 10mg od
Carvedilol 6.25mg bid
Atorvastatin 40mg tab odhs
Risk stratification – high risk
9/17/22 – cardio notes
Bp 130/80, hr 80, rr 20, o2 sat 98%
2d echo – dilated left ventricular cavity qith
adequate contractility and wall motion, EF 69%
Ideally for sestamibi scan and myocardial
perfusion imaging
9/17/22 – gen surgery notes
Bp 130/80, hr 80, rr 20, o2 sat 98% Still for laparoscopic gastrectomy w/
gastrojejunostomy and jejuno-jejunostomy
9/18/22 – IM notes
Noted an episode of desaturation
O2 sat of 92%
No dob, sob , chest pain, headache, n/v
Abg result
Ph 7.56 pco2 33.6, p02 65.5, hco3 29.6, be 7.4,
o2sat 94.5
K 3.1
For abg now
For cbc na k, bun, crea
Hook to nasal cannula at 3-4 lpms
9/19/22 – gen surgery notes
Stable vs
No dob, sob, chestpain
For re-strat of clearances prior to OR
9/20/22 – IM notes
Noted hypoglycemic episode
Cbg 60mg/dl
No dob sob chestpain n/v
Bp 130/70
Hr 86
rr 20
02sat 98
Pls refer to dietary department for patient
education regarding dietary modification
Pls refer to psych department for evaluation of
eating disorder
9/24/22 – 2pm Anesthesia preop
Proposed as semi urgent with scheduled or date Patient seen and examined
History, labs chart reviewed
Main service verbalized possible family
conference prior to scheduled OR
Awaiting proposed schedule of family and
interdepartmental conference
COD updated
9/24/22 – 6pm Anesthesia preop
Cod informed
Pls schedule multidisciplinary conference prior
to family conference
OR schedule to follow based on the outcome of
said conferences.
9/26/22 – 7 am – gen surgery notes
May we suggest to do per department
grandrounds with other services, if not, we will
have zoom meeting with other consultants
Suggest also to discharge the patiuent for now
and re admit once final clearance is given
9/26/22 – 10am – gen surgery notes
May go home anytime
Pls inquire with all services if any laboratory or
workup needed for preoperativr preparations
Will coordinate with family regarding schedule
of family conference
conference preop obes (1).pptx

More Related Content

Similar to conference preop obes (1).pptx

fggh
fgghfggh
A case report of acute pancrititis
A case report of acute pancrititisA case report of acute pancrititis
A case report of acute pancrititis
Hao-Chen Ke
 
Bowelobstruction
BowelobstructionBowelobstruction
Bowelobstruction
Zodzai Zabzaa
 
Colorectal carcinoma
Colorectal carcinomaColorectal carcinoma
Colorectal carcinoma
Danish Sagheer
 
Weekly death round
Weekly death roundWeekly death round
Weekly death round
Beka Aberra
 
Bariactic surgery.pptx
Bariactic surgery.pptxBariactic surgery.pptx
Bariactic surgery.pptx
YungChan6
 
Pulmonary Alveolar Proteinosis
Pulmonary Alveolar ProteinosisPulmonary Alveolar Proteinosis
Pulmonary Alveolar Proteinosis
Salman Alim
 
Case Presentation on Perforated Duodenal Ulcer
Case Presentation on Perforated Duodenal UlcerCase Presentation on Perforated Duodenal Ulcer
Case Presentation on Perforated Duodenal Ulcer
ksaigowtham
 
Hepatic adenoma case presentation.dr quiyum
Hepatic adenoma case presentation.dr quiyumHepatic adenoma case presentation.dr quiyum
Hepatic adenoma case presentation.dr quiyum
MD Quiyumm
 
德國
德國德國
德國
tinaho
 
Celiac common presentation of a uncommon disease saved with date
Celiac common presentation of a uncommon disease  saved with dateCeliac common presentation of a uncommon disease  saved with date
Celiac common presentation of a uncommon disease saved with date
Muhammad Arshad
 
Morning Report Thursday, February 1st 2024.pptx
Morning Report Thursday, February 1st 2024.pptxMorning Report Thursday, February 1st 2024.pptx
Morning Report Thursday, February 1st 2024.pptx
TezarAndrean1
 
pre op contoh
pre op contohpre op contoh
pre op contoh
kampav
 
DENGU HLH - FINAL.pptx
DENGU HLH - FINAL.pptxDENGU HLH - FINAL.pptx
DENGU HLH - FINAL.pptx
ShaheenAhmed44
 
Mortality meeting
Mortality meetingMortality meeting
Mortality meeting
Dr Musfiqur Rahman
 
Emphysematous pyelonephritis- case discussion
Emphysematous pyelonephritis- case discussionEmphysematous pyelonephritis- case discussion
Emphysematous pyelonephritis- case discussion
Dr Abdul sherwani
 
Cirrhotic Ascites Review
Cirrhotic Ascites Review   Cirrhotic Ascites Review
Cirrhotic Ascites Review
Brian Lee
 
Covid case2-1.pptx
Covid case2-1.pptxCovid case2-1.pptx
Covid case2-1.pptx
mohamedRabee37
 
Presentation3.pptx
Presentation3.pptxPresentation3.pptx
Presentation3.pptx
mohamedRabee37
 

Similar to conference preop obes (1).pptx (20)

fggh
fgghfggh
fggh
 
A case report of acute pancrititis
A case report of acute pancrititisA case report of acute pancrititis
A case report of acute pancrititis
 
Bowelobstruction
BowelobstructionBowelobstruction
Bowelobstruction
 
Colorectal carcinoma
Colorectal carcinomaColorectal carcinoma
Colorectal carcinoma
 
Weekly death round
Weekly death roundWeekly death round
Weekly death round
 
Bariactic surgery.pptx
Bariactic surgery.pptxBariactic surgery.pptx
Bariactic surgery.pptx
 
Pulmonary Alveolar Proteinosis
Pulmonary Alveolar ProteinosisPulmonary Alveolar Proteinosis
Pulmonary Alveolar Proteinosis
 
Case Presentation on Perforated Duodenal Ulcer
Case Presentation on Perforated Duodenal UlcerCase Presentation on Perforated Duodenal Ulcer
Case Presentation on Perforated Duodenal Ulcer
 
Hepatic adenoma case presentation.dr quiyum
Hepatic adenoma case presentation.dr quiyumHepatic adenoma case presentation.dr quiyum
Hepatic adenoma case presentation.dr quiyum
 
德國
德國德國
德國
 
 
Celiac common presentation of a uncommon disease saved with date
Celiac common presentation of a uncommon disease  saved with dateCeliac common presentation of a uncommon disease  saved with date
Celiac common presentation of a uncommon disease saved with date
 
Morning Report Thursday, February 1st 2024.pptx
Morning Report Thursday, February 1st 2024.pptxMorning Report Thursday, February 1st 2024.pptx
Morning Report Thursday, February 1st 2024.pptx
 
pre op contoh
pre op contohpre op contoh
pre op contoh
 
DENGU HLH - FINAL.pptx
DENGU HLH - FINAL.pptxDENGU HLH - FINAL.pptx
DENGU HLH - FINAL.pptx
 
Mortality meeting
Mortality meetingMortality meeting
Mortality meeting
 
Emphysematous pyelonephritis- case discussion
Emphysematous pyelonephritis- case discussionEmphysematous pyelonephritis- case discussion
Emphysematous pyelonephritis- case discussion
 
Cirrhotic Ascites Review
Cirrhotic Ascites Review   Cirrhotic Ascites Review
Cirrhotic Ascites Review
 
Covid case2-1.pptx
Covid case2-1.pptxCovid case2-1.pptx
Covid case2-1.pptx
 
Presentation3.pptx
Presentation3.pptxPresentation3.pptx
Presentation3.pptx
 

Recently uploaded

Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPromoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
PsychoTech Services
 
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
bkling
 
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
rishi2789
 
Netter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdfNetter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdf
BrissaOrtiz3
 
Osteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdfOsteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdf
Jim Jacob Roy
 
Abortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentationAbortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentation
AksshayaRajanbabu
 
Role of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of HyperthyroidismRole of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of Hyperthyroidism
Dr. Jyothirmai Paindla
 
Best Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and IndigestionBest Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and Indigestion
Swastik Ayurveda
 
Histololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptxHistololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptx
AyeshaZaid1
 
Top Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in IndiaTop Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in India
SwisschemDerma
 
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptxPost-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
FFragrant
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
Health Advances
 
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
rishi2789
 
Efficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in AyurvedaEfficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in Ayurveda
Dr. Jyothirmai Paindla
 
Journal Article Review on Rasamanikya
Journal Article Review on RasamanikyaJournal Article Review on Rasamanikya
Journal Article Review on Rasamanikya
Dr. Jyothirmai Paindla
 
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptxREGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
LaniyaNasrink
 
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
19various
 
A Classical Text Review on Basavarajeeyam
A Classical Text Review on BasavarajeeyamA Classical Text Review on Basavarajeeyam
A Classical Text Review on Basavarajeeyam
Dr. Jyothirmai Paindla
 
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
rishi2789
 
Chapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptxChapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptx
Earlene McNair
 

Recently uploaded (20)

Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPromoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
 
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
 
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
 
Netter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdfNetter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdf
 
Osteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdfOsteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdf
 
Abortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentationAbortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentation
 
Role of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of HyperthyroidismRole of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of Hyperthyroidism
 
Best Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and IndigestionBest Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and Indigestion
 
Histololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptxHistololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptx
 
Top Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in IndiaTop Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in India
 
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptxPost-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
 
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
 
Efficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in AyurvedaEfficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in Ayurveda
 
Journal Article Review on Rasamanikya
Journal Article Review on RasamanikyaJournal Article Review on Rasamanikya
Journal Article Review on Rasamanikya
 
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptxREGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
 
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
 
A Classical Text Review on Basavarajeeyam
A Classical Text Review on BasavarajeeyamA Classical Text Review on Basavarajeeyam
A Classical Text Review on Basavarajeeyam
 
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
 
Chapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptxChapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptx
 

conference preop obes (1).pptx

  • 2.  To discuss the case of a patient scheduled for elective surgery who was classified as high risk with unmodifiable factors
  • 3. SITUATION:  T. T.  67 years old, female  Preoperative Diagnosis  Metabolic syndrome , obese 3  Proposed Operation  Laparoscopic gastrectomy w/ reux en y bypass  Problem:  Patient is classified high risk endo, pulmo, cardio wise Date of operation: Tentative
  • 4.
  • 5.  T.T., 67 years old female, married, roman catholic, currently residing at alunahaw st., navotas city, admitted for the first time at our institution last September 13, 2022 due to chief complaint of excessive wait gain.
  • 7.  10 years prior to consult, patient was apparently well with medium built until noticed increasing appetite and increase in food cravings. There was no change in physical activities during this time.  During the interim, there was noted weight gain. There was no food restriction, no physical exercise.  4 months prior to consult, patient started having difficulty in ambulation due to increasing wait and increasing body mass, during this time, ambulation was assisted and required support. There was also occasional dob, easy fatigability. Consult at a clinic was done and was advised diet modification and increase in physical exercise.
  • 8.  Few days prior to consult, patient experienced pain at both knees during assisted ambulation, consult was done at a private clinic and was prescribed unrecalled medications.  Persistence of symptoms prompted consult and subsequent admission to our institution.
  • 9.  Past medical history: (+) Hypertension (-+) Diabetes Mellitus (+) bronchial asthma –last attack 1 month ago  Family history: hypertension – maternal side Surgical history unremarkable  Personal and social history: Non alchoholic Non smoker No illicit drug use
  • 10.  General survey: Conscious, coherent, not in cardiopulmonary distress, GCS 15 Wt. 105kgs Bmi – 46.6kg/m2 – obese III  Vital signs: BP: 130/80mmhg, HR 64bpm, RR 24cpm, Temp 37.3C, 02 sat 98% on nasal cannula
  • 11.  HEENT:  Pink palpebral conjunctivae, anicteric sclerae, no naso-aural discharge, no tonsillopharyngeal congestion, no cervical lymphadenopathy  mouth opening of 4cm, no limitation in Neck mobility, mallampati classification 3, full dentition  Short and thick neck  Chest and Lungs:  Symmetrical chest expansion, no retractions, Crackles bilateral
  • 12.  Cardiovascular: Adynamic precordium, normal rate, regular rhythm, no murmurs  Abdomen: Flabby, no tenderness noted  Extremities: No gross deformities, full and equal pulses, no cyanosis, no edema
  • 13. ANESTHETIC ASSESSMENT AND PLAN  ASA Physical status 3  Obese 3 – BMI of 46.6kg/m2  Pneumonia-moderate risk  Heart failure symptoms  Aki secondary to infection  Hypertension controlled  Dm type 2 controlled
  • 14.  IM Risk Strat: high risk  IM Cardio: high risk  Ecg – complete RBBB. 2d echo result of dilated left cavity  IM Endo: high risk  Cbg range of 68 to137, hba1c of 6.0  IM pulmo : high risk  Ongoing pneumonia, history if bronchial asthma, episode of desaturations  RCRI class 3 – 2points  dm not requiring insulin(0), hf symptoms (+1), type of surgery-intrabdominal (+1)  Ariscat score: 66 – high risk  67, episode of 90% o2sat (+8), recent respiratory infection (+17), upper abdominal sx (+15), duration of more than 3 hrs, non emergency(+23)
  • 15.
  • 16. Cbc 8/26/22 Hgb 129 hct 38.5 platelets 297 wbc 6.8 Blood chemistry 8/26/22 na 140.9 k 3.5 crea 85.9 bun 2.69 fbs 5.7 hba1c 6.7 ast 17.8 alt 11.46
  • 17. Bleeding parameters 8/26/22 pt 12.2 ptt 33.5 inr 0.95 % activity 94.5 Lipid profile 8/26/22 HDL 1.43 LDL 3.15 VLDL 0.52 TRIGLYCERIDE 1.15 TOTAL CHOLESTEROL 5.10
  • 18.  2d echo results  Dilated left ventricular cavity, with adequate wall motion and contractility  Mild mitral and pulmonary regurgitation  Aortic sclerosis  Ejection fraction of 69%
  • 20.
  • 21. 9/13/22 -patient was admitted by the surgery department Admitting labs requested Medications started – omeprazole 40mg OD, cefuroxime 750mg q8, paracetamol 300mg tiv prn Surgical plan of laparoscopic gastrectomy reu en y bybass Monitor vs q4 Monitor i/o q shift For im, pulmo, cardio, endo clearance
  • 22. 9/14/22 Requested ABG Started ceftriaxone 2g tiv OD Started azithromycin 500mg tiv OD Assessment Cap –MR Metabolic syndrome Obese type III Dm type 2 – controlled Hypertension st. 2, controlled Risk stratification – high risk
  • 23. 9/14/22c Requested ABG Started ceftriaxone 2g tiv OD Started azithromycin 500mg tiv OD For cbg TID premeals Tx. Insulin HR 10 u SC for cbg > 100mg/dl D5050 if cbg <80mg/dl Risk stratification – high risk
  • 24. 9/15/22 Bp 140/80, hr 74, rr 20, o2 sat 96% 2d echo – dilated left ventricular cavity qith adequate contractility and wall motion, EF 69% Continue amlodipine 10mg od Carvedilol 6.25mg bid Atorvastatin 40mg tab odhs Risk stratification – high risk
  • 25. 9/17/22 – cardio notes Bp 130/80, hr 80, rr 20, o2 sat 98% 2d echo – dilated left ventricular cavity qith adequate contractility and wall motion, EF 69% Ideally for sestamibi scan and myocardial perfusion imaging 9/17/22 – gen surgery notes Bp 130/80, hr 80, rr 20, o2 sat 98% Still for laparoscopic gastrectomy w/ gastrojejunostomy and jejuno-jejunostomy
  • 26. 9/18/22 – IM notes Noted an episode of desaturation O2 sat of 92% No dob, sob , chest pain, headache, n/v Abg result Ph 7.56 pco2 33.6, p02 65.5, hco3 29.6, be 7.4, o2sat 94.5 K 3.1 For abg now For cbc na k, bun, crea Hook to nasal cannula at 3-4 lpms 9/19/22 – gen surgery notes Stable vs No dob, sob, chestpain For re-strat of clearances prior to OR
  • 27. 9/20/22 – IM notes Noted hypoglycemic episode Cbg 60mg/dl No dob sob chestpain n/v Bp 130/70 Hr 86 rr 20 02sat 98 Pls refer to dietary department for patient education regarding dietary modification Pls refer to psych department for evaluation of eating disorder
  • 28. 9/24/22 – 2pm Anesthesia preop Proposed as semi urgent with scheduled or date Patient seen and examined History, labs chart reviewed Main service verbalized possible family conference prior to scheduled OR Awaiting proposed schedule of family and interdepartmental conference COD updated 9/24/22 – 6pm Anesthesia preop Cod informed Pls schedule multidisciplinary conference prior to family conference OR schedule to follow based on the outcome of said conferences.
  • 29. 9/26/22 – 7 am – gen surgery notes May we suggest to do per department grandrounds with other services, if not, we will have zoom meeting with other consultants Suggest also to discharge the patiuent for now and re admit once final clearance is given 9/26/22 – 10am – gen surgery notes May go home anytime Pls inquire with all services if any laboratory or workup needed for preoperativr preparations Will coordinate with family regarding schedule of family conference